|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
1,770,000,000 |
Market
Cap: |
300.33(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$132.51 - $182.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 560 |
Guru Rank Value : 3 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
80,031 |
461,916 |
540,416 |
831,596 |
Total Sell Value |
$14,256,265 |
$81,646,316 |
$93,320,391 |
$138,453,569 |
Total People Sold |
2 |
9 |
9 |
12 |
Total Sell Transactions |
2 |
11 |
13 |
29 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Tilton Glenn F |
Director |
|
2014-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,764 |
24,505 |
|
- |
|
Liddy Edward M |
Director |
|
2014-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,764 |
10,420 |
|
- |
|
Rapp Edward J |
Director |
|
2014-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,764 |
7,799 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2014-03-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,075 |
386,328 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2014-03-04 |
4 |
S |
$51.19 |
$245,706 |
D/D |
(4,799) |
395,403 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2014-03-03 |
4 |
S |
$50.19 |
$198,259 |
D/D |
(3,948) |
180,068 |
|
- |
|
Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
|
2014-03-03 |
4 |
S |
$50.03 |
$207,284 |
D/D |
(4,143) |
273,585 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2014-03-03 |
4 |
S |
$50.24 |
$122,760 |
D/D |
(2,443) |
85,828 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2014-03-03 |
4 |
S |
$50.09 |
$144,356 |
D/D |
(2,882) |
205,138 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2014-02-28 |
4 |
D |
$51.91 |
$512,507 |
D/D |
(9,873) |
184,016 |
|
- |
|
Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
|
2014-02-28 |
4 |
D |
$50.91 |
$1,116,965 |
D/D |
(21,940) |
277,728 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2014-02-28 |
4 |
D |
$51.91 |
$328,902 |
D/D |
(6,336) |
88,271 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2014-02-28 |
4 |
D |
$50.91 |
$779,890 |
D/D |
(15,319) |
208,020 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2014-02-28 |
4 |
D |
$50.91 |
$339,519 |
D/D |
(6,669) |
107,384 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2014-02-28 |
4 |
D |
$50.91 |
$2,383,148 |
D/D |
(46,811) |
400,202 |
|
- |
|
Hurwich Thomas A. |
VP, Controller |
|
2014-02-28 |
4 |
D |
$50.91 |
$171,058 |
D/D |
(3,360) |
61,448 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
53,770 |
193,889 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
30,140 |
114,053 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
47,260 |
223,339 |
|
- |
|
Hurwich Thomas A. |
VP, Controller |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,220 |
64,808 |
|
- |
|
Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
54,590 |
302,793 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
30,140 |
94,607 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
162,960 |
447,013 |
|
- |
|
Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
|
2014-02-18 |
4 |
D |
$50.73 |
$406,905 |
D/D |
(8,021) |
248,203 |
|
- |
|
Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
|
2014-02-18 |
4 |
OE |
$43.21 |
$385,779 |
D/D |
8,928 |
256,224 |
|
- |
|
765 Records found
|
|
Page 27 of 31 |
|
|